NEWS & EVENTS | STAY UP TO DATE
Topadur secures FDA Orphan Drug Designation for TOP-N53
Topadur Pharma AG today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its investigational therapy…
9. September 2025